Drug of choice for Herpes simplex encephalitis is :
Now, the core concept would be the antiviral medication that's most effective against HSV in the CNS. Acyclovir is the go-to because it's a nucleoside analog that inhibits viral DNA synthesis. It's important to note that it's effective when given intravenously. The mechanism involves phosphorylation by viral thymidine kinase, which then inhibits the viral DNA polymerase. This is crucial because other antivirals might not cross the blood-brain barrier as effectively.
For the correct answer explanation, I need to detail why acyclovir is the right choice. It's the drug of choice because it's been shown in studies to reduce mortality and morbidity when administered early. The standard regimen is 10-14 days of IV therapy. Also, newer drugs like valacyclovir or famciclovir might be used in some cases, but acyclovir is still the first line.
Now, the wrong options. Let's assume the options are A: Ganciclovir, B: Foscarnet, C: Acyclovir, D: Ribavirin. Wait, the user didn't list the options, but the correct answer is missing. Let me think of common distractors. Ganciclovir is used for CMV, Foscarnet is for resistant HIV or CMV, Ribavirin is for respiratory viruses. So each of these would be incorrect because they don't target HSV effectively in the CNS.
Clinical pearl: Acyclovir's prompt administration is critical. Delay can lead to severe neurological damage or death. Remembering that HSV encephalitis is a classic indication for acyclovir is key. Also, knowing that it's given IV for maximum efficacy in the CNS.
Putting it all together, the explanation should cover the core concept, why acyclovir is correct, why others are wrong, and a high-yield fact. Need to keep it concise but thorough, within the character limit.
**Core Concept**
Herpes simplex encephalitis (HSE) is a life-threatening CNS infection caused by HSV-1, typically managed with antiviral agents that inhibit viral DNA synthesis. The drug of choice must effectively cross the blood-brain barrier and target herpesvirus-specific enzymes.
**Why the Correct Answer is Right**
**Acyclovir** is the drug of choice for HSE. It is a guanosine analog that requires phosphorylation by viral thymidine kinase to form acyclovir triphosphate, which competitively inhibits viral DNA polymerase and causes chain termination. Its lipophilic nature allows CNS penetration, and IV administration ensures therapeutic concentrations in the brain. Early initiation (within 24-48 hours of symptom onset) reduces mortality from >70% to <20%.
**Why Each Wrong Option is Incorrect**
**Option A: Ganciclovir** –